AIAI NetraMark Holdings Inc.
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.…
Industry Peers
Health Information ServicesKey Statistics
About NetraMark Holdings (TSE: AIAI)
›
NetraMark Holdings (TSE: AIAI) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.4900 CAD on 19 November 2026, down 57.4% over 52 weeks. Its 52-week range is 0.4000 CAD to 1.280 CAD: the price is 61.7% below the high and 22.5% above the low.
Its market capitalisation is 46.37M CAD.
NetraMark Holdings reports return on equity of -284.6%.
It holds more cash than debt, a net cash position of 3.17M CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.